157 related articles for article (PubMed ID: 10980386)
1. Modulation of TCR recognition of MHC class II/peptide by processed remote N- and C-terminal epitope extensions.
Bonomi G; Moschella F; Ombra MN; Del Pozzo G; Granier C; De Berardinis P; Guardiola J
Hum Immunol; 2000 Aug; 61(8):753-63. PubMed ID: 10980386
[TBL] [Abstract][Full Text] [Related]
2. Recognition of core and flanking amino acids of MHC class II-bound peptides by the T cell receptor.
Sant'Angelo DB; Robinson E; Janeway CA; Denzin LK
Eur J Immunol; 2002 Sep; 32(9):2510-20. PubMed ID: 12207335
[TBL] [Abstract][Full Text] [Related]
3. Microheterogeneity in the recognition of a HLA-DR2-restricted T cell epitope from a meningococcal outer membrane protein.
Wiertz E; van Gaans-van den Brink J; Hoogerhout P; Poolman J
Eur J Immunol; 1993 Jan; 23(1):232-9. PubMed ID: 7678224
[TBL] [Abstract][Full Text] [Related]
4. Predicting CD4 T-cell epitopes based on antigen cleavage, MHCII presentation, and TCR recognition.
Schneidman-Duhovny D; Khuri N; Dong GQ; Winter MB; Shifrut E; Friedman N; Craik CS; Pratt KP; Paz P; Aswad F; Sali A
PLoS One; 2018; 13(11):e0206654. PubMed ID: 30399156
[TBL] [Abstract][Full Text] [Related]
5. Modeling alternative binding registers of a minimal immunogenic peptide on two class II major histocompatibility complex (MHC II) molecules predicts polarized T-cell receptor (TCR) contact positions.
Murray JS; Fois SD; Schountz T; Ford SR; Tawde MD; Brown JC; Siahaan TJ
J Pept Res; 2002 Mar; 59(3):115-22. PubMed ID: 11985705
[TBL] [Abstract][Full Text] [Related]
6. T cell receptor recognition of MHC class II-bound peptide flanking residues enhances immunogenicity and results in altered TCR V region usage.
Carson RT; Vignali KM; Woodland DL; Vignali DA
Immunity; 1997 Sep; 7(3):387-99. PubMed ID: 9324359
[TBL] [Abstract][Full Text] [Related]
7. Antigenicity of HIV-derived T helper determinants in the context of carrier recombinant proteins: effect on T helper cell repertoire selection.
Manca F; De Berardinis P; Fenoglio D; Ombra MN; Li Pira G; Saverino D; Autiero M; Lozzi L; Bracci L; Guardiola J
Eur J Immunol; 1996 Oct; 26(10):2461-9. PubMed ID: 8898961
[TBL] [Abstract][Full Text] [Related]
8. An endogenously processed self peptide and the corresponding exogenous peptide bound to the same MHC class II molecule could be distinct ligands for TCR with different kinetic stability.
Gyotoku T; Fukui Y; Sasazuki T
Eur J Immunol; 1998 Dec; 28(12):4050-61. PubMed ID: 9862341
[TBL] [Abstract][Full Text] [Related]
9. Conversion of tyrosine to the inflammation-associated analog 3'-nitrotyrosine at either TCR- or MHC-contact positions can profoundly affect recognition of the MHC class I-restricted epitope of lymphocytic choriomeningitis virus glycoprotein 33 by CD8 T cells.
Hardy LL; Wick DA; Webb JR
J Immunol; 2008 May; 180(9):5956-62. PubMed ID: 18424715
[TBL] [Abstract][Full Text] [Related]
10. Amino acid residues that flank core peptide epitopes and the extracellular domains of CD4 modulate differential signaling through the T cell receptor.
Vignali DA; Strominger JL
J Exp Med; 1994 Jun; 179(6):1945-56. PubMed ID: 7515103
[TBL] [Abstract][Full Text] [Related]
11. Differing processing requirements of four recombinant antigens containing a single defined T-cell epitope for presentation by major histocompatibility complex class II.
Colledge L; Sun MY; Lin W; Blackburn CC; Reay PA
Immunology; 2001 Jul; 103(3):343-50. PubMed ID: 11454063
[TBL] [Abstract][Full Text] [Related]
12. Molecular basis of a dominant T cell response to an HIV reverse transcriptase 8-mer epitope presented by the protective allele HLA-B*51:01.
Motozono C; Kuse N; Sun X; Rizkallah PJ; Fuller A; Oka S; Cole DK; Sewell AK; Takiguchi M
J Immunol; 2014 Apr; 192(7):3428-34. PubMed ID: 24600035
[TBL] [Abstract][Full Text] [Related]
13. T cell recognition of major histocompatibility complex class II complexes with invariant chain processing intermediates.
Morkowski S; Goldrath AW; Eastman S; Ramachandra L; Freed DC; Whiteley P; Rudensky AYu
J Exp Med; 1995 Nov; 182(5):1403-13. PubMed ID: 7595211
[TBL] [Abstract][Full Text] [Related]
14. Functional mapping of MHC class II polymorphic residues. The alpha-chain controls the specificity for binding an Ad-versus an A k-restricted peptide and the beta-chain region 65-67 controls T cell recognition but not peptide binding.
Lee JM; McKean DJ; Watts TH
J Immunol; 1991 May; 146(9):2952-9. PubMed ID: 1849939
[TBL] [Abstract][Full Text] [Related]
15. Diverse fine specificity and receptor repertoire of T cells reactive to the major VP1 epitope (VP1230-250) of Theiler's virus: V beta restriction correlates with T cell recognition of the c-terminal residue.
Kim BS; Bahk YY; Kang HK; Yauch RL; Kang JA; Park MJ; Ponzio NM
J Immunol; 1999 Jun; 162(12):7049-57. PubMed ID: 10358147
[TBL] [Abstract][Full Text] [Related]
16. The flexibility of the TCR allows recognition of a large set of naturally occurring epitope variants by HIV-specific cytotoxic T lymphocytes.
Buseyne F; Rivière Y
Int Immunol; 2001 Jul; 13(7):941-50. PubMed ID: 11431424
[TBL] [Abstract][Full Text] [Related]
17. Functional Recognition by CD8+ T Cells of Epitopes with Amino Acid Variations Outside Known MHC Anchor or T Cell Receptor Recognition Residues.
Wilson KL; Xiang SD; Plebanski M
Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32630213
[TBL] [Abstract][Full Text] [Related]
18. Direct phenotypic analysis of human MHC class I antigen presentation: visualization, quantitation, and in situ detection of human viral epitopes using peptide-specific, MHC-restricted human recombinant antibodies.
Cohen CJ; Sarig O; Yamano Y; Tomaru U; Jacobson S; Reiter Y
J Immunol; 2003 Apr; 170(8):4349-61. PubMed ID: 12682272
[TBL] [Abstract][Full Text] [Related]
19. Two MHC surface amino acid differences distinguish foreign peptide recognition from autoantigen specificity.
Basu D; Horvath S; O'Mara L; Donermeyer D; Allen PM
J Immunol; 2001 Mar; 166(6):4005-11. PubMed ID: 11238647
[TBL] [Abstract][Full Text] [Related]
20. Activation of T cells by the ragged tail of MHC class II-presented peptides of the measles virus fusion protein.
Muller CP; Ammerlaan W; Fleckenstein B; Krauss S; Kalbacher H; Schneider F; Jung G; Wiesmüller KH
Int Immunol; 1996 Apr; 8(4):445-56. PubMed ID: 8671631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
